Objective To investigate the clinical efficacy of renal artery embolization combined with laparoscopic tumor removal for the treatment of giant renal hamartoma. Methods The clinical data of 8 cases of giant renal hamartoma treated by renal artery embolization combined with laparoscopic enucleation of tumors from July 2013 to February 2018 were retrospectively analyzed. Results Eight patients underwent successful operation. The aver-age operation time was(105.13±16.63)min,the average intraoperative blood loss was(77.5±43.67)ml,and the average postoperative hospital stay was(7.75±1.28)d. No blood transfusion during and after operation. The Scr was(83.88±13.11)μmol/L and the eGFR was(37.0±6.23)ml/(min·1.73 m2)in 3 months after operation. There was no significant difference between the two groups(P>0.05). Postoperative pathological find-ings confirmed renal hamartoma. The average follow-up was 24.75 months. CT and Scr and eGFR were reviewed 3 months after operation. All showed no local recurrence or impaired renal function. Conclusion Renal artery embolization combined with laparoscopic tumor removal can safely and effec-tively treat exogenous giant renal hamartoma. The short-term follow-up results show that the therapeutic effect has basically reached the expected goal.%目的 初步探讨肾动脉栓塞联合腹腔镜下肿瘤剜除术治疗巨大肾错构瘤的临床疗效.方法 回顾性分析2013年7月至2018年2月收治接受肾动脉栓塞联合腹腔镜下肿瘤剜除术8例巨大肾错构瘤的临床资料.结果 8例患者手术均获得成功,平均手术时间(105.13±16.63) min,术中平均出血量(77.5±43.67)ml,术后平均住院时间(7.75±1.28)d.术中及术后均未输血,术后3个月复查Scr为(83.88±13.11) μmol/L,患肾eGFR为(37.0±6.23)ml/(min·1.73 m2),与术前相比差异均无统计学意义(P均>0.05).术后病理检查结果证实为肾错构瘤.平均随访24.75个月,术后3个月复查CT及Scr、eGFR,均显示无局部复发或肾功能受损.结论 肾动脉栓塞联合腹腔镜下肿瘤剜除可安全有效地治疗巨大肾错构瘤,短期随访结果显示治疗效果满意,值得临床推广.
展开▼
